A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.
Hammer
Scott M
SM
Columbia University, New York, NY, USA. smh48@columbia.edu
Bassett
Roland
R
Squires
Kathleen E
KE
Fischl
Margaret A
MA
Demeter
Lisa M
LM
Currier
Judith S
JS
Mellors
John W
JW
Morse
Gene D
GD
Eron
Joseph J
JJ
Santana
Jorge L
JL
DeGruttola
Victor
V
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000821:virology; D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000328:Adult; D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D015224:Dideoxynucleosides / Q000008:administration & dosage; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D008297:Male; D019888:Nelfinavir / Q000008:administration & dosage; D063065:Organophosphonates; D010078:Oxazines / Q000008:administration & dosage; D010641:Phenotype; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D017211:Treatment Failure; D000099227:Abacavir
D000225:Adenine; D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D015224:Dideoxynucleosides; D019469:Indinavir; D019888:Nelfinavir; D063065:Organophosphonates; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir; C098320:efavirenz; C106812:adefovir dipivoxil